Search for: "D J v. C R" Results 1 - 20 of 2,762
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Jun 2024, 4:00 am by SOQUIJ
PÉNAL (DROIT) — infraction — infractions routières — conduite d’un véhicule avec facultés affaiblies — règle interdisant les condamnations multiples — conduite avec une présence d’alcool dans l’organisme (art. [read post]
16 Jun 2024, 4:00 am by SOQUIJ
Intitulé : R. c. [read post]
12 Jun 2024, 1:06 pm by Administrator
For this past month, the three most-consulted English-language decisions were: R. v. [read post]
19 May 2024, 4:01 am by Administrator
Criminal Law: Language RightsR. v. [read post]
17 May 2024, 4:43 am by Matthias Weller
by Achim Czubaiko, Research Fellow („Wissenschaftlicher Mitarbeiter“) and PhD Candidate, supported by the German Scholarship Foundation, Institute for German and International Civil Procedural Law, University of Bonn. [read post]
24 Apr 2024, 11:27 am by admin
”[10] Fourth, the plaintiffs’ claims were before Chief Judge Nancy J. [read post]
17 Apr 2024, 2:05 am by Frank Cranmer
As to Ground 3, Linden J accepted that the Governing Body had had due regard to the matters required by section 149(1)(a)-(c) of the Equality Act 2010 [267], and even if he had concluded that Ground 3 was well founded, he would have refused relief [273]. [read post]
15 Apr 2024, 9:01 pm by renholding
Those third parties included Senator Cynthia Lummis (R-WY), the Blockchain Association, Katie Cox and Professors Peter Conti-Brown, Morgan Ricks,3Julie Andersen Hill and David Zaring.4 In his amicus brief, former Senator Toomey stated that the purpose for his amendment requiring the Federal Reserve Board to maintain a database was to increase the transparency and public accountability of the Federal Reserve Banks’ master account approval… [read post]
15 Apr 2024, 3:56 pm by Kenan Farrell
Restoration 1 by J&D, LLC (SD 7/12/2023) –  An initial pretrial conference is scheduled on May 8, 2024. [read post]
13 Apr 2024, 3:33 pm by admin
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]
8 Apr 2024, 10:08 am by admin
As a practical matter, the burden shifts to the party that wishes to challenge the relied upon facts and data to learn more about the cited studies to show that the facts and data are not sufficient under Rule 702(b), and that the testimony is not the product of reliable methods under Rule 702(c). [read post]